- Stocks
- Pharma & Healthcare
- Laxmi Dental
Laxmi Dental share price
NSE: LAXMIDENTLPharma & HealthcareMedical Instruments & Supplies
Laxmi Dental at a glance
Laxmi Dental (NSE: LAXMIDENTL) closed at ₹182.10 on 19 Oct 2026, down 1.57% on the day. With a market capitalisation of ₹1,001 Cr, it ranks 1467th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Instruments & Supplies.
At its last close the stock traded at 34.6× trailing earnings, against a return on equity of 11.9% in FY26. Over the past year the share price has fallen 42.7%. Its 52-week range is ₹155.88 (30 Mar 2026) to ₹344.80 (11 Nov 2025); the last close is 47.2% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹72 Cr (+19.5% year on year) and net profit ₹11 Cr (+201.4%), on a consolidated basis. Promoters held 41.80% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹1,001 CrRank 1467 on NSE
- P/E (trailing)
- 34.6×
- Price to book
- 3.56×FY26
- EPS (TTM)
- ₹5.32to Q4 FY26
- ROE
- 11.9%FY26
- ROCE
- 13.7%FY26
- Debt to equity
- 0FY26
- Net profit margin
- 9.5%FY26
- Book value / share
- ₹44.27FY26
- 52-week high
- ₹344.8011 Nov 2025
- 52-week low
- ₹155.8830 Mar 2026
- 1-year return
- −42.7%
- RSI (14-day)
- 35.3
Returns to 19 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −1.57% | −7.6% | −8.0% | −19.2% | −42.7% |
Laxmi Dental quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹60 Cr | ₹57 Cr | ₹60 Cr | ₹60 Cr | ₹64 Cr | ₹71 Cr | ₹64 Cr | ₹72 Cr |
| Revenue YoY | — | — | +27.9% | +10.7% | +6.8% | +25.5% | +5.9% | +19.5% |
| Net profit | ₹14 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹7 Cr | ₹8 Cr | ₹1 Cr | ₹11 Cr |
| Net profit YoY | — | — | +810.0% | −36.1% | −46.8% | +102.1% | −74.5% | +201.4% |
| Net margin | 22.8% | 6.6% | 6.0% | 5.8% | 11.4% | 10.7% | 1.5% | 14.7% |
| EPS | ₹4.94 | ₹1.14 | ₹0.88 | ₹0.79 | ₹1.53 | ₹1.59 | ₹0.37 | ₹1.83 |
Laxmi Dental financials
| Item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | ₹137 Cr | ₹162 Cr | ₹194 Cr | ₹239 Cr | — |
| Operating profit | −₹5 Cr | −₹4 Cr | ₹9 Cr | ₹25 Cr | — |
| Net profit | −₹19 Cr | −₹5 Cr | ₹16 Cr | ₹25 Cr | — |
| EPS (₹) | −₹3.00 | −₹1.00 | ₹5.00 | ₹6.00 | — |
| Cash from operations | −₹2 Cr | ₹14 Cr | ₹8 Cr | ₹44 Cr | — |
| Total debt | ₹10 Cr | ₹11 Cr | ₹15 Cr | ₹11 Cr | ₹0 Cr |
| Shareholders' equity | ₹9 Cr | ₹6 Cr | ₹31 Cr | ₹209 Cr | ₹243 Cr |
Laxmi Dental shareholding pattern
| Holder | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|
| Promoters | 41.70% | 41.70% | 41.70% | 41.77% | 41.80% |
| Foreign institutions | 33.59% | 32.39% | 32.45% | 31.21% | 30.10% |
| Domestic institutions | 14.31% | 11.85% | 10.83% | 10.52% | 10.89% |
| Non-institutions | 10.40% | 14.06% | 15.02% | 16.50% | 17.21% |
Laxmi Dental vs peers
The listed Pharma & Healthcare companies nearest to Laxmi Dental by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| BAJAJHCAREBajaj Healthcare | ₹339.90 | −2.05% | −27.4% | ₹1,144 Cr | 50.4 | — |
| BAFNAPHBafna Pharmaceuticals | ₹470.55 | +1.99% | +195.5% | ₹1,113 Cr | 100.3 | — |
| LINCOLNLincoln Pharmaceuticals | ₹533.40 | −2.58% | +0.9% | ₹1,068 Cr | 12.2 | — |
| SIGACHISigachi Industries | ₹26.70 | −4.13% | −32.9% | ₹1,020 Cr | — | — |
| LAXMIDENTLLaxmi Dental | ₹182.10 | −1.57% | −42.7% | ₹1,001 Cr | 34.6 | — |
| THEMISMEDThemis Medicare | ₹100.30 | −5.47% | −23.6% | ₹924 Cr | — | — |
| SGRLShree Ganesh Re | ₹694.00 | −0.83% | — | ₹891 Cr | 50.3 | — |
Ask anything about Laxmi Dental
Pivot answers on the live chart with evidence you can check, and tests strategies against LAXMIDENTL's own history. Try: “Why has LAXMIDENTL moved over the last three months?” · “Backtest a 50-day moving-average crossover on LAXMIDENTL over five years” · “Compare LAXMIDENTL with BAJAJHCARE on margins and valuation”
Frequently asked questions about Laxmi Dental
What is the share price of Laxmi Dental today?
Laxmi Dental (NSE: LAXMIDENTL) last closed at ₹182.10 on 19 Oct 2026. Its 52-week high is ₹344.80 and its 52-week low is ₹155.88.
What is the market cap of Laxmi Dental?
Laxmi Dental's market capitalisation is ₹1,001 Cr (₹1,001 Cr) at the 19 Oct 2026 close, ranking 1467th among the NSE companies Pivot tracks.
What is the P/E ratio of Laxmi Dental?
Laxmi Dental trades at a trailing P/E of 34.6. The median P/E of the 4 closest Pharma & Healthcare peers by market cap is 50.4.
What is the ROE and ROCE of Laxmi Dental?
Return on equity was 11.9% in FY26 and return on capital employed was 13.7% in FY26 (consolidated figures).
Is Laxmi Dental a debt-free company?
Laxmi Dental is close to debt-free: its debt-to-equity ratio was 0 in FY26.
What were Laxmi Dental's latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Laxmi Dental reported revenue of ₹72 Cr, +19.5% year on year, and net profit of ₹11 Cr, +201.4% year on year.
How has Laxmi Dental stock performed over the last year?
Laxmi Dental's share price has fallen 42.7% over the past year, −19.2% over three months and −8.0% over one month, to the 19 Oct 2026 close.
What is the shareholding pattern of Laxmi Dental?
As of 30 Jun 2026: promoters 41.80%, foreign institutions 30.10%, domestic institutions 10.89%, non-institutions 17.21%.
Who are Laxmi Dental's competitors?
The listed Pharma & Healthcare companies closest to Laxmi Dental by market cap are Bajaj Healthcare, Bafna Pharmaceuticals, Lincoln Pharmaceuticals, Sigachi Industries, Themis Medicare and Shree Ganesh Re.
Is Laxmi Dental a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Laxmi Dental's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on LAXMIDENTL against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 19 Oct 2026 (returns and ratios at the 19 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with L · all NSE stocks · this page as text